基于微模拟中成本效益标准的个性化治疗规则
Niklaus Meier1,2, Ana Cecilia Quiroga Gutierrez3, Mark Pletscher4
1Institute of Pharmaceutical Medicine (ECPM), University of Basel, Basel, Switzerland. niklaus.meier@bfh.ch.
PharmacoEconomics
|November 10, 2025
概括
个性化治疗规则 (ITR) 通过根据患者特征量身定制治疗来优化成本效益. 应用在微模拟数据上的分类树在推导这些规则方面被证明是优越的,考虑到患者的异质性.
科学领域:
- 卫生经济学 卫生经济学
- 统计建模 统计建模
- 决策科学科学 决策科学
背景情况:
- 成本效益分析 (CEA) 通常使用人口级数据.
- 个性化治疗规则 (ITR) 可以通过考虑到患者异质性来增强CEA.
- 统计学习为从模拟数据设计ITR提供了新的方法.
研究的目的:
- 为设计个性化治疗规则 (ITR) 提出和评估统计学习方法.
- 通过使用微观模拟模型,通过根据患者个体特征量身定制治疗来优化成本效益.
- 为了比较ITR导出不同统计学习技术的性能.
主要方法:
- 定义了最佳ITR及其在成本效益方面的价值.
- 应用LASSO回归,分类树和策略树来模拟患者数据.
- 基于增量净货币收益 (NMB),计算速度和可解释性的比较方法.
- 评估了参数和随机不确定性对ITR的影响.
- 使用微模拟模型用于血友病B的插图方法.
主要成果:
- 根据定义的标准,两层分类树被发现是最合适的方法.
- 最佳分类树根据年均出血率和年龄的值分配了治疗方法.
- 门值表现出不确定性,确定了95%的可信范围.
- 随机不确定性被证明会影响ITR的增量值.
结论:
- 预计分类树在类似的微显模拟模型中对ITR导出具有优势.
- 由于随机不确定性对ITRs的重大影响,准确的患者路径表示至关重要.
- 未来的研究应该进一步探索经验模型和ITRs的现实应用.
相关概念视频
01:23Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
392
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
392
01:24Dosage Regimen: Individualization
160
Individualization in dosing regimens is the customization of medication doses for individual patients. Its necessity arises from the goal of maximizing therapeutic benefits while minimizing risks. This approach is pivotal because human responses to drugs can vary widely; what is effective for one person may be inadequate or excessive for another. Interpatient (intersubject) variability refers to differences in drug responses between individuals, while intrapatient (intrasubject) variability...
160
01:26Pharmacokinetic Models: Comparison and Selection Criterion
319
Physiological and compartmental models are valuable tools used in studying biological systems. These models rely on differential equations to maintain mass balance within the system, ensuring an accurate representation of the dynamic processes at play.
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
319
01:23Dosage Regimen Designs: Nomograms and Tabulations
166
Nomograms and tabulations are vital tools used by clinicians to design accurate and individualized dosage regimens. These instruments provide a straightforward method for adjusting dosages based on individual patient characteristics, including age, weight, and physiological condition. The foundation of a drug's nomogram is population pharmacokinetic data collected and analyzed using specific models. This data simplifies complex equations, presenting them diagrammatically or tabularly for easy...
166
01:28Dosage Regimens: Designs and Approaches
248
Designing a dosage regimen, which refers to the manner of drug administration, is a complex process involving the selection of drug dose, route, and frequency. This process is underpinned by pharmacokinetic parameters derived from tests and population averages. These parameters are then tailored to patient-specific variables such as diagnosis, demographics, and allergy status. Once therapy commences, therapeutic response monitoring is critical and achieved through clinical and physical...
248
01:12Analysis of Population Pharmacokinetic Data
659
Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...
659